Amazon (NSDQ:AMZN) reportedly has a healthcare skunkworks lab working in areas including electronic medical records and telemedicine, dubbed 1492, according to a CNBC report. The team, headquartered in Seattle, is engaged in both hardware and software products, according to the report. Amazon’s secretive team is reportedly considering development in fields that would see them pushing and […]
The future of medical technology could involve artificial intelligence, virtual reality and even direct connections to the human brain. A panel at DeviceTalks, led by Worrell Design’s director of advanced development, Derek Mathers, discussed how technological developments like Amazon’s Alexa and the accumulation of big data could shape future trends in medtech. Wielding big data […]
While billions of dollars are being poured into healthcare artificial intelligence plays with major companies leading the way, the technology still has a long way to go until it’s challenging the expertise of doctors on the front lines, according to a new Xconomy report. To reach that point, companies will not only have to invest […]
MannKind Corporation said today it withdrew an offer that would have made ex-Insulet (NSDQ:PODD) CEO Duane DeSisto its new CEO only 19 days after officially posting its offer to DeSisto. The offer was withdrawn as objections were raised by DeSisto’s former employer Insulet, who said the new position would violate its non-competition agreement, which will be […]
Royal Philips (NYSE:PHG) said it signed on to a new platform from Amazon (NSDQ:AMZN) designed to facilitate the so-called “Internet of Things,” aiming to link and collect data from mobile healthcare devices. Amazon Web Services said its AWS IoT platform is designed to allow companies to “store, process, analyze, and act on the volumes of data generated by […]
MASSDEVICE ON CALL — Another tech giant may be about to jump into the healthcare space.
Modern Healthcare reported that "leaders" from online retailer Amazon took a meeting last month with the FDA’s global regulatory operations & policy deputy commissioner, Howard Sklamberg, as well as other agency officials. The paper noted the meeting in one of the FDA’s recent calendar updates.